Hokuyaku Takeyama HoldingsInc (3055) Stock Overview
Engages in the wholesale of pharmaceutical products and medical devices in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 3055 from our risk checks.
3055 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Hokuyaku Takeyama Holdings,Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥896.00 |
| 52 Week High | JP¥948.00 |
| 52 Week Low | JP¥742.00 |
| Beta | -0.0052 |
| 1 Month Change | -3.76% |
| 3 Month Change | -1.54% |
| 1 Year Change | 3.46% |
| 3 Year Change | 41.10% |
| 5 Year Change | 20.92% |
| Change since IPO | -3.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3055 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | -2.7% | -4.6% | -2.3% |
| 1Y | 3.5% | 14.0% | 32.8% |
Return vs Industry: 3055 underperformed the JP Healthcare industry which returned 14% over the past year.
Return vs Market: 3055 underperformed the JP Market which returned 32.8% over the past year.
Price Volatility
| 3055 volatility | |
|---|---|
| 3055 Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in JP Market | 8.9% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 3055 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3055's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 1,605 | Masanobu Manabe | www.hokutake.co.jp |
Hokuyaku Takeyama Holdings,Inc. engages in the wholesale of pharmaceutical products and medical devices in Japan. It also sells medical devices, such as treatment and facility equipment, image diagnostic equipment, optical equipment, artificial organ-related equipment, bioinformation-related equipment, physical therapy equipment, and testing equipment, as well as general-purpose products, such as syringes to implants used in orthopedic surgery.
Hokuyaku Takeyama Holdings,Inc. Fundamentals Summary
| 3055 fundamental statistics | |
|---|---|
| Market cap | JP¥18.83b |
| Earnings (TTM) | JP¥1.96b |
| Revenue (TTM) | JP¥299.67b |
Is 3055 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3055 income statement (TTM) | |
|---|---|
| Revenue | JP¥299.67b |
| Cost of Revenue | JP¥278.37b |
| Gross Profit | JP¥21.30b |
| Other Expenses | JP¥19.34b |
| Earnings | JP¥1.96b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 93.12 |
| Gross Margin | 7.11% |
| Net Profit Margin | 0.65% |
| Debt/Equity Ratio | 0.02% |
How did 3055 perform over the long term?
See historical performance and comparisonDividends
Does 3055 pay a reliable dividends?
See 3055 dividend history and benchmarks| Hokuyaku Takeyama HoldingsInc dividend dates | |
|---|---|
| Ex Dividend Date | Mar 30 2026 |
| Dividend Pay Date | Jun 30 2026 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 106 days |
Does 3055 pay a reliable dividends?
See 3055 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/14 20:22 |
| End of Day Share Price | 2026/03/13 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hokuyaku Takeyama Holdings,Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
